Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2026-01-03 @ 8:22 PM
Study NCT ID:
NCT00083668
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2004-05-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2004-05-27
First Submit QC Date:
None
Study First Post Date:
2004-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-06-06
Last Update Post Date:
2011-06-08
Last Update Post Date Type:
ESTIMATED